89 related articles for article (PubMed ID: 29187445)
1. The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J
Anticancer Res; 2017 Dec; 37(12):6685-6695. PubMed ID: 29187445
[TBL] [Abstract][Full Text] [Related]
2. The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Müller SC; Kristiansen G; Ellinger J
Ann Diagn Pathol; 2018 Jun; 34():18-26. PubMed ID: 29661722
[TBL] [Abstract][Full Text] [Related]
3. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.
Lee YJ; Han ME; Baek SJ; Kim SY; Oh SO
PLoS One; 2015; 10(6):e0130826. PubMed ID: 26110885
[TBL] [Abstract][Full Text] [Related]
4. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
Shukla A; Srivastava S; Darokar J; Kulshreshtha R
Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
[TBL] [Abstract][Full Text] [Related]
5. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
6. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
7. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
8. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
9. The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma.
Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J; Syring I
Cancer Biomark; 2018; 21(4):839-847. PubMed ID: 29400661
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
12. The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J
Oncol Lett; 2018 Sep; 16(3):3013-3021. PubMed ID: 30127891
[TBL] [Abstract][Full Text] [Related]
13. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
14. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
15. Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.
Zhang YX; Qin CP; Zhang XQ; Wang QR; Zhao CB; Yuan YQ; Yang JG
Tumour Biol; 2017 Apr; 39(4):1010428317699119. PubMed ID: 28443476
[TBL] [Abstract][Full Text] [Related]
16. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
[TBL] [Abstract][Full Text] [Related]
17. Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network.
Tan C; Zhu S; Chen Z; Liu C; Li YE; Zhu M; Zhang Z; Zhang Z; Zhang L; Gu Y; Liang Z; Boyer TG; Ouyang K; Evans SM; Fang X
PLoS Genet; 2021 Sep; 17(9):e1009785. PubMed ID: 34506481
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
19. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
20. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
